Dealing with Corruption Risks, Compliance and Value Management
January 2019. Global analytical and medical diagnostic companies are active in diverse jurisdictions and business cultures. Thus they are quite vulnerable to internal and external deviance. For many years the Eurofins Group has been escaping scandals which plague others in the laboratory sector, and a number of ethics and other behavioural codes are publicly available. But is on paper enough? How does the company enforce compliance and prevent corruptive practice? Hugues Vaussy, Director of Group Finance with global responsibilities for Insurance and Risk Management, Investor Relations, as well as capital market transactions answered B2Bioworld's questions.Reading time: 13 min
Read Now: |
Other articles recommended
B2Bioworld offers you background information
Straight talking to MECA countries
Governance, anti-corruption, agriculture, digitization, citizen engagement, freedom of press, AMIS and Georgia
Corporate Compliance: Training the paper tiger to purr, show its teeth, or jump on
Michael Andreas Schulz, CFO and Compliance Officer, Bayer CropScience describes the workings of the system
“We have some of the biggest databases in the world…”
No Mercy with Violators of Corporate Compliance
Rüdiger Scheitza, Labour Director and Member of the Board Bayer CropScience
Innovation – Try Again, Fail Again, Fail Better
Ulrich Betz, Vice President Department Head Innovation & Entrepreneurship Incubator; Merck Biopharma